Repeated High-dose Inhaled Corticosteroids for Asthma



Status:Withdrawn
Conditions:Asthma
Therapuetic Areas:Pulmonary / Respiratory Diseases
Healthy:No
Age Range:18 - 50
Updated:5/10/2018
Start Date:May 2008
End Date:September 2011

Use our guide to learn which trials are right for you!

The purpose of this study is to to compare the effects of high-dose Inhaled Corticosteroids
(ICS) vs. placebo in adults with chronic stable asthma.


Inclusion criteria:

- Physician diagnosis of asthma.

- Age ≥18 years and ≤50 years

- Evidence of airflow obstruction as measured by spirometry and flow-volume loop per
American Thoracic Society guidelines.

- Treatment for asthma with:

- daily inhaled corticosteroids and long-acting beta2-agonists, AND

- as-needed use of a short-acting beta2-agonist

Exclusion criteria:

- History of >10 pack-year tobacco use

- Other pulmonary or cardiac diagnosis that is actively being treated

- History of adverse events or allergy to fluticasone

- Systemic corticosteroid therapy within 7 days of study visit

- Inability to obtain written informed consent
We found this trial at
1
site
5801 South Ellis Avenue
Chicago, Illinois 60637
 773.702.1234
University of Chicago One of the world's premier academic and research institutions, the University of...
?
mi
from
Chicago, IL
Click here to add this to my saved trials